INDICATIONS & USAGE SECTION
Indications: Temporarily relieves symptoms of general physical weakness and listlessness, including: fatigue; sore muscles & joints; dry skin; absence of sexual desire; occasional sleeplessness.
Indications: Temporarily relieves symptoms of general physical weakness and listlessness, including: fatigue; sore muscles & joints; dry skin; absence of sexual desire; occasional sleeplessness.
NDC#: 2728100396
VIVACITY
Energy Medicine with DNA
Homeopathic Fast-Acting Oral Spray
1.0 Fl Oz (30 mL)
Alcohol 9% v/v
Keep out of reach of children.
Directions: Adults only: spray twice under the tongue, three times a day. This bottle contains about a 1 month supply.
Warnings: Keep out of reach of children. If pregnant or breast feeding, ask a doctor before using product. Stop use and ask a doctor if symptoms persist more than 3 days, worsen, or if new symptoms occur.
Tamper Evident Seal: Do not use if seal around neck of bottle is broken or missing. The letters HPUS indicate that ingredients are officially included in the Homeopathic Pharmacopoeia of the United States.
Distributed by SUNWAY BIOTECH, LLC
Oak HIlls CA 92344 U.S.A. info@sunwaybiotech.com
Active Ingredients: Equal volumes of each ingredient: Alfalfa 2X HPUS, Aralia Quinquefolia 2X HPUS, Arnica Montana 3X HPUS, Avena Sativa 2X HPUS, DNA 6X HPUS, DNA 12X HPUS, Galium Aparine 3X HPUS, Hypericum Perforatum 200C HPUS, Oleum Animale 6X HPUS, Pituitarium Posterium 8X HPUS, Rhus Toxicodendron 200C HPUS, RNA 6X HPUS, Thuja Occidentalis 30C HPUS.
Inactive Ingredients: Alcohol 9% v/v, Glycerin 10% v/v, Purified Water.
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| f47a510b-6679-4664-b2d6-47b5c4afe7cc | Product name | 4 | 20260217 |
| 030ce964-9b2d-45aa-b5d3-f78ce03ef61c | Product name | 2 | 20250515 |
| 0306390c-dd77-4363-afe0-63c58088b2a1 | Product name | 1 | 20220120 |
| 503ea967-4b9c-48cf-9e87-c7975295849d | Product name | 2 | 20220120 |
| 190f2a5b-bbc8-65c7-fcb0-97891307b917 | Product name | 1 | 20140508 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 55138-001-01 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-44c5-f424-e053-dadaa90a57ce | 58f0330d-0c16-4505-913d-26cccf42ae99 |
| 55138-001-02 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-44c5-f424-e053-dadaa90a57ce | 58f0330d-0c16-4505-913d-26cccf42ae99 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 55138-001-01 | Brain Power | 30 mL in 1 BOTTLE, SPRAY | SPRAY | 30 | 2 | |
| 55138-001-02 | Brain Power | 60 mL in 1 BOTTLE, SPRAY | SPRAY | 60 | 2 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 55138-001 | BRAIN POWER (SEMECARPUS ANACARDIUM JUICE, ARNICA MONTANA, CALCIUM FLUORIDE, SILYBUM MARIANUM SEED, CINCHONA OFFICINALIS BARK, HERRING SPERM DNA, GINKGO, EGG PHOSPHOLIPIDS, ACHILLEA MILLEFOLIUM, PHOSPHORIC ACID, SACCHAROMYCES CEREVISIA RNA, SILICON DIOXIDE, AND ZINC SULPHATE HEPTAHYDRATE) SPRAY [INTEGRA HEALTH INTERNATIONAL, S.A. DE C.V.] | 2 | Legacy NDC, 2 package rows | 20150516_58f0330d-0c16-4505-913d-26cccf42ae99.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| ACHILLEA MILLEFOLIUM | ACTIVE INGREDIENT | 2FXJ6SW4PK | 2 | |
| ARNICA MONTANA | ACTIVE INGREDIENT | O80TY208ZW | 2 | |
| CALCIUM FLUORIDE | ACTIVE INGREDIENT | O3B55K4YKI | 2 | |
| CINCHONA OFFICINALIS BARK | ACTIVE INGREDIENT | S003A158SB | 2 | |
| EGG PHOSPHOLIPIDS | ACTIVE INGREDIENT | 1Z74184RGV | 2 | |
| GINKGO | ACTIVE INGREDIENT | 19FUJ2C58T | 2 | |
| HERRING SPERM DNA | ACTIVE INGREDIENT | 51FI676N6F | 2 | |
| PHOSPHORIC ACID | ACTIVE INGREDIENT | E4GA8884NN | 2 | |
| SACCHAROMYCES CEREVISIAE RNA | ACTIVE INGREDIENT | J17GBZ5VGX | 2 | |
| SEMECARPUS ANACARDIUM JUICE | ACTIVE INGREDIENT | Y0F0BU8RDU | 2 | |
| SILICON DIOXIDE | ACTIVE INGREDIENT | ETJ7Z6XBU4 | 2 | |
| SILYBUM MARIANUM SEED OIL | ACTIVE INGREDIENT | NYY23HEN06 | 2 | |
| ZINC SULFATE HEPTAHYDRATE | ACTIVE INGREDIENT | N57JI2K7WP | 2 | |
| ACHILLEA MILLEFOLIUM | ACTIVE MOIETY | 2FXJ6SW4PK | 2 | |
| ARNICA MONTANA | ACTIVE MOIETY | O80TY208ZW | 2 | |
| CINCHONA OFFICINALIS BARK | ACTIVE MOIETY | S003A158SB | 2 | |
| COLLOIDAL SILICON DIOXIDE | ACTIVE MOIETY | ETJ7Z6XBU4 | 2 | |
| EGG PHOSPHOLIPIDS | ACTIVE MOIETY | 1Z74184RGV | 2 | |
| FLUORIDE ION | ACTIVE MOIETY | Q80VPU408O | 2 | |
| GINKGO | ACTIVE MOIETY | 19FUJ2C58T | 2 | |
| HERRING SPERM DNA | ACTIVE MOIETY | 51FI676N6F | 2 | |
| PHOSPHORIC ACID | ACTIVE MOIETY | E4GA8884NN | 2 | |
| SACCHAROMYCES CEREVISIAE RNA | ACTIVE MOIETY | J17GBZ5VGX | 2 | |
| SEMECARPUS ANACARDIUM JUICE | ACTIVE MOIETY | Y0F0BU8RDU | 2 | |
| SILYBUM MARIANUM SEED OIL | ACTIVE MOIETY | NYY23HEN06 | 2 | |
| ZINC CATION | ACTIVE MOIETY | 13S1S8SF37 | 2 | |
| ALCOHOL | INACTIVE INGREDIENT | 3K9958V90M | 2 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 2 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 2 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 55138-001 | 55138-001-01, 55138-001-02 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| SEMECARPUS ANACARDIUM JUICE | Y0F0BU8RDU | ACTIB |
| ARNICA MONTANA | O80TY208ZW | ACTIB |
| CALCIUM FLUORIDE | O3B55K4YKI | ACTIB |
| SILYBUM MARIANUM SEED OIL | NYY23HEN06 | ACTIB |
| CINCHONA OFFICINALIS BARK | S003A158SB | ACTIB |
| HERRING SPERM DNA | 51FI676N6F | ACTIB |
| GINKGO | 19FUJ2C58T | ACTIB |
| EGG PHOSPHOLIPIDS | 1Z74184RGV | ACTIB |
| ACHILLEA MILLEFOLIUM | 2FXJ6SW4PK | ACTIB |
| PHOSPHORIC ACID | E4GA8884NN | ACTIB |
| SACCHAROMYCES CEREVISIAE RNA | J17GBZ5VGX | ACTIB |
| SILICON DIOXIDE | ETJ7Z6XBU4 | ACTIB |
| ZINC SULFATE HEPTAHYDRATE | N57JI2K7WP | ACTIM |
| ALCOHOL | 3K9958V90M | IACT |
| GLYCERIN | PDC6A3C0OX | IACT |
| WATER | 059QF0KO0R | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / TOPICAL | 9971 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | DROPS / ORAL | 210 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / INTRAMUSCULAR | 450 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GUM, CHEWING / BUCCAL | 230 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / DENTAL | 1.8 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET, FILM COATED / ORAL | 1.55 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GEL / OPHTHALMIC | 0.88 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY, METERED / SUBLINGUAL | 29 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | ELIXIR / ORAL | 5621 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SYSTEM / TOPICAL | 18144 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | AEROSOL / TOPICAL | 3 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION / ORAL | 26208 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION/ DROPS / AURICULAR (OTIC) | 25 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / TRANSDERMAL | 49.37 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | DROPS / ORAL | 300 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | DOUCHE / VAGINAL | 1 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CONCENTRATE / BUCCAL | 679 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / DENTAL | 15 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | ELIXIR / ORAL | 13675 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CAPSULE, EXTENDED RELEASE / ORAL | 8 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SHAMPOO / TOPICAL | 714 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / INTRAVENOUS | 33750 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE, EXTENDED RELEASE / ORAL | 265 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / INTRAVENOUS | 15 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL, METERED / TOPICAL | 541 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / RESPIRATORY (INHALATION) | 5 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOAP / TOPICAL | 0.76 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SYRUP / ORAL | 16734 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, SPRAY / TOPICAL | 561 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | AEROSOL, FOAM / TOPICAL | 21 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET, CHEWABLE / ORAL | 12 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SUSPENSION / RECTAL | 0.35 %v/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE, COATED / ORAL | 14.21 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SPONGE / TOPICAL | 2 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SPRAY, METERED / NASAL | 13 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GEL / TOPICAL | 500 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SHAMPOO / TOPICAL | 5 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION/ DROPS / OPHTHALMIC | 2.5 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / INTRAVESICAL | 7892 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION / AURICULAR (OTIC) | 0.05 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET / PERIODONTAL | 0.53 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE / ORAL | 3487 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE, LIQUID FILLED / ORAL | 185 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | EMULSION / INTRAVENOUS | 2.2 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | MOUTHWASH / BUCCAL | 100 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SUSPENSION / ORAL | 681 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUPPOSITORY / VAGINAL | 227.9 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / SUBCUTANEOUS | 149 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / AURICULAR (OTIC) | 63.64 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / ORAL | 6624 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / ORAL | 150.68 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | PASTE, DENTIFRICE / DENTAL | 18 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / TOPICAL | 1971 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SYSTEM / IONTOPHORESIS | 168.1 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION/ DROPS / ORAL | 750 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | JELLY / VAGINAL | NA | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL, METERED / TRANSDERMAL | 3675 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / DENTAL | 12.8 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION, CONCENTRATE / ORAL | 200 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / SUBCUTANEOUS | 6.1 %v/v |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| f94f554a-7a96-4039-bd0b-4c7d45d4598c | 58f0330d-0c16-4505-913d-26cccf42ae99 | 2015-05-15 | Warnings | f94f554a-7a96-4039-bd0b-4c7d45d4598c 58f0330d-0c16-4505-913d-26cccf42ae99 |
Adverse event summaries are temporarily unavailable. Other product information remains available.